Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 219-227

  Berriel, Edgardo ^a   Hill, Marcelo ^a   Barcia, Juan J ^a,b   Ubillos, Luis ^a   Gonzalez, Mariela ^b   Detjen, Gisselle ^a   Rondan, Mariella ^a   Navarrete, Héctor ^a   Osinaga, Eduardo ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

Animal models; Colon cancer; O glycosylation; Sialyl Tn antigen; Tn antigen

Indexed keywords

DIMETHYLHYDRAZINE; GLYCOPROTEIN; MUCIN; SIALOSYL TN ANTIGEN; SIALOSYL-TN ANTIGEN; TN ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COLON; COLON TUMOR; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PRECANCER; RAT; WISTAR RAT;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; COLON; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIMETHYLHYDRAZINES; FEMALE; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; MUCINS; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 24644453684     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Baldus S and Hanisch F: Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. Adv Cancer Res 79: 201-248, 2000. (Pubitemid 30228125)
2. Itzkowitz S, Bloom E, Kokal W, Modin G, Hakomori S and Kim Y: Sialosyl-Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960-1966, 1990. (Pubitemid 20385969)
3. Bresalier R, Niv Y, Byrd J, Duh Q, Toribara N, Rockwell R, Dahiya R and Kim Y: Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87: 1037-1045, 1991.
4. Brockhausen I: Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473: 67-95, 1999.
5. Itzkowitz S, Yuan M, Montgomery C, Kjeldsen T, Takahashi H, Bigbee W and Kim Y: Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 49: 197-204, 1989. (Pubitemid 19024432)
6. Springer G: Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis and immunotherapy. J Mol Med 75: 594-602, 1997.
7. Yang J, Byrd C, Siddiki B, Chung, Y, Okuno M, Sowa M, Kim Y, Matta K and Brockhausen I: Alterations of O-glycan biosynthesis in human colon-cancer tissues. Glycobiology 4: 873-884, 1994.
8. Itzkowitz S, Bloom E, Lau T and Kim Y: Mucin-associated Tn- and sialosyl-Tn-antigen expression in colorectal polyps. Gut 33: 518-523, 1992.
9. Danishefsky SJ and Allen JR: From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines. Angew Chem Int Ed Engl 39: 836-863, 2000. (Pubitemid 30217267)
10. Singhal A, Fohn M and Hakomori S: Induction of N-acetyl-galactosamine-O- serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res 51: 1406-1411, 1991.
11. Lo-Man R, Bay S, Vichier-Guerre S, Deriaud E, Cantacuzene D and Leclerc C: A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy. Cancer Res 59: 1520-1524, 1999. (Pubitemid 29160120)
12. Lo-Man R, Vichier-Guerre S, Bay S, Deriaud E, Cantacuzene D and Leclerc C: Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope. J Immunol 166: 2849-2854, 2001. (Pubitemid 32173527)
13. Greene F, Lamb L and Barwick M: Colorectal cancer in animal models - a review. J Surg Res 43: 476-487, 1987. (Pubitemid 18031777)
14. Babino A, Oppezzo P, Bianco S, Barrios E, Berois N, Navarrete H and Osinaga E: Tn antigen is a pre-cancerous biomarker in breast tissue and serum in N-Nitrosomethylurea-induced rat mammary carcinogenesis. Int J Cancer 86: 753-759, 2000. (Pubitemid 30350188)
15. Amberger H: Different autochthonous models of colorectal cancer in the rat. J Cancer Res Clin Oncol 111: 157-159, 1986.
16. Labarriere N, Piau J, Otry C, Denis M, Lustenberger P, Meflah K and Le Pendu J: H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54: 6275-6281, 1994. (Pubitemid 24378665)
17. Bird R: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93: 55-71, 1995.
18. Sunter JP, Appleton DR, Wright NA and Watson AJ: Pathological features of the colonic tumors induced in rats by the administration of 1,2-Dimethylhydrazine. Virchows Arch 29: 211-223, 1978.
19. Sanchez Negrette M, Borda JT, Montenegro MA and Lertora JW: Histological and histochemical study of hyperplastic and dysplastic lesions of the large intestine in Cebus Apella (primate) treated with 1,2-dimethylhydrazine. Acta Physiol Pharmacol Ther Latinoam 48: 211-223, 1998. (Pubitemid 29042319)
20. Osinaga E, Bay S, Tello D, Babino A, Pritsch O, Assemat K, Cantacuzene D, Nakada H and Alzari P: Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectrospcopy. FEBS Lett 469: 24-28, 2000. (Pubitemid 30119862)
21. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H and Hakomori S: Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 48: 2214-2220, 1988.
22. Towbin H, Staehlin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979. (Pubitemid 9256559)
23. Osinaga E, Babino A, Grosclaude J, Cairoli E, Batthyany C, Bianchi S, Signorelli S, Varangot M, Musé I and Roseto A: Development of an immuno-lectin-enzymatic assay for the detection of serum carcinoma-associated glycoproteins bearing Tn determinant. Int J Oncol 8: 401-406, 1996. (Pubitemid 26047274)
24. Pancino G, Osinaga E, Charpin C, Mistro D, Barque J and Roseto A: Purification and characterization of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4. Br J Cancer 63: 390-398, 1991.
25. Osinaga E, Pancino G, Porchet N, Berois N, De Cremoux P, Mistro D, Aubert JP, Calvo F and Roseto A: Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant. Breast Cancer Res Treat 32: 139-152, 1994. (Pubitemid 24313339)
26. O'Boyle KP, Goya V, Zuckier LS, Chun S and Bhargava K: Expression of human tumor mucin-associated carbohydrate epitopes, including sialylated Tn, and localization of murine monoclonal antibodies CC49 and B72.3 in a syngeneic rat colon carcinoma model. J Immunother 16: 251-261, 1994.
27. Meichenin M, Rocher J, Galanina O, Bovin N, Nifantev N, Sherman A, Cassagnau E, Heymann M, Bara J, Fraser R and Le Pendu J: Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation. Cancer Res 60: 5499-5507, 2000.
28. Medina M, Velez D, Asenjo JA, Egea G, Real FX, Gil J and Subiza JL: Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A 10) raised against murine Ehrlich tumor cells. Cancer Res 59: 1061-1070, 1999. (Pubitemid 29135967)
29. Chang WW: Histogenesis of colon cancer in experimental animals. Scand J Gastroenterol 19: 27-43, 1984.
30. Siu I M, Pretlow TG, Amini S and Pretlow TP: Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol 150: 1805-1813, 1997. (Pubitemid 27193826)
31. Corpet D and Taché S: Most effective colon cancer chemopreventive agents in rats: a review of aberrant crypt foci and tumour data, ranked by potency. Nutr Cancer 43: 1-21, 2002. (Pubitemid 35387251)
32. Cheng L and Lai MD: Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 9: 2642-2649, 2003. (Pubitemid 38054431)
33. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV and Gallinger S: Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54: 5527-5530, 1994. (Pubitemid 24346239)
34. Augenlicht LH, Richards C, Corner G and Pretlow TP: Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 12: 1767-1772, 1996. (Pubitemid 26146301)
35. Terasawa K, Furumoto H, Kamada M and Aono T: Expression of Tn and sialyl-Tn antigens in neoplastic transformation of uterine cervical epithelial cells. Cancer Res 56: 2229-2232, 1996. (Pubitemid 26119930)
36. Cho SH, Sahin A, Hortobagyi G, Hittelman W and Dhingra K: Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy. Cancer Res 54: 6302-6305, 1994.
37. Creeth M, Bhaskar K and Horton J: The separation and characterization of bronchial glycoproteins by density-gradient methods. Biochem J 167: 557-569, 1977. (Pubitemid 8240972)
38. Moniaux N, Escande F, Porchet N, Aubert JP and Batra SK: Structural organization and classification of the human mucin genes. Front Biosci 6: D1192-D1206, 2001.
39. Gambús G, De Bolos C, Andreu D, Franci C, Egea G and Real FX: Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenterology 104: 93-102, 1993. (Pubitemid 23040011)
40. Bara J, Chastre E, Mahiou J, Singh R, Forgue-Lafitte M, Hollande E and Godeau F: Gastric Ml mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 75: 767-773, 1998. (Pubitemid 28145826)
41. Bara J, Forgue-Lafitte ME, Maurin N, Flejou JF and Zimber A: Abnormal expression of gastric mucin in human and rat aberrant crypt foci during colon carcinogenesis. Tumour Biol 24: 109-115, 2003. (Pubitemid 37465047)
42. Freire T, Medeiros A, Reis C, Real FX and Osinaga E: Biochemical characterization of soluble Tn glycoproteins from malignant effusions of patients with carcinomas. Oncol Rep 10: 1577-1585, 2003.
43. Thurner M, Rusconi S and Berger E: Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J Clin Invest 91: 2103-2110, 1993. (Pubitemid 23141484)
44. Brockhausen I, Yang J, Lehotay M, Ogata S and Itzkowitz S: Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated sialyl-Tn antigen expression. Biol Chem 382: 219-232, 2001. (Pubitemid 32243930)
45. Hakomori S: Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491: 369-402, 2001.
46. Galli-Stampino L, Meinjohanns E, Frische K, Meldal M, Jensen T, Werdelin O and Mouritsen S: T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res 57: 3214-3222, 1997. (Pubitemid 27351738)
47. Livingston P and Ragupathi G: Carbohydrate vaccine that induce antibodies against cancer. II. Previous experience and future plans. Cancer Immunol Immunother 45: 10-19, 1997. (Pubitemid 27444465)